Renowned melanoma researcher and immunotherapy expert Dr. Jeffrey S. Weber's passing leaves a lasting impact on cancer treatment, education, and research.
Physicians face challenges in getting Medicare coverage for Wegovy (semaglutide) despite its FDA approval for reducing cardiovascular risk in obese patients.